| Dr Mary Joel Sturm, OD | |
|
224 S Gateway Pl, Suite 101, Jenks, OK 74037-3460 | |
| (918) 747-2020 | |
| (918) 747-2056 |
| Full Name | Dr Mary Joel Sturm |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 30 Years |
| Location | 224 S Gateway Pl, Jenks, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437279924 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2142 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oklahoma Medical Eye Group | 7719291202 | 9 |
News Archive
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
UBM Medica US announces that Cancer Network, a leading online community for oncologists and others who treat cancer and the online home of the journal ONCOLOGY, presents exclusive coverage of the European Society for Medical Oncology (ESMO) 2014 Congress, held September 26–30 in Madrid, Spain.
The first test that can detect the presence of the dengue virus itself rather than antibodies to the virus has been approved for use by the US Food and Drug Administration.
End-stage renal disease (ERSD) is the last stage of chronic kidney disease where the kidneys function at under 10 to 15 percent of their normal capacity. At this stage, kidneys cannot effectively remove waste or excess fluid from the blood system, and dialysis or a kidney transplant is necessary to live.
› Verified 7 days ago
| Provider Name | Northeastern State University College Of Optometry |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437106333 PECOS PAC ID: 0941112528 Enrollment ID: O20031103000296 |
News Archive
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
UBM Medica US announces that Cancer Network, a leading online community for oncologists and others who treat cancer and the online home of the journal ONCOLOGY, presents exclusive coverage of the European Society for Medical Oncology (ESMO) 2014 Congress, held September 26–30 in Madrid, Spain.
The first test that can detect the presence of the dengue virus itself rather than antibodies to the virus has been approved for use by the US Food and Drug Administration.
End-stage renal disease (ERSD) is the last stage of chronic kidney disease where the kidneys function at under 10 to 15 percent of their normal capacity. At this stage, kidneys cannot effectively remove waste or excess fluid from the blood system, and dialysis or a kidney transplant is necessary to live.
› Verified 7 days ago
| Provider Name | Njvoc Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851630313 PECOS PAC ID: 0345474383 Enrollment ID: O20131008000056 |
News Archive
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
UBM Medica US announces that Cancer Network, a leading online community for oncologists and others who treat cancer and the online home of the journal ONCOLOGY, presents exclusive coverage of the European Society for Medical Oncology (ESMO) 2014 Congress, held September 26–30 in Madrid, Spain.
The first test that can detect the presence of the dengue virus itself rather than antibodies to the virus has been approved for use by the US Food and Drug Administration.
End-stage renal disease (ERSD) is the last stage of chronic kidney disease where the kidneys function at under 10 to 15 percent of their normal capacity. At this stage, kidneys cannot effectively remove waste or excess fluid from the blood system, and dialysis or a kidney transplant is necessary to live.
› Verified 7 days ago
| Provider Name | Oklahoma Medical Eye Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1902283229 PECOS PAC ID: 7719291202 Enrollment ID: O20150728004591 |
News Archive
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
UBM Medica US announces that Cancer Network, a leading online community for oncologists and others who treat cancer and the online home of the journal ONCOLOGY, presents exclusive coverage of the European Society for Medical Oncology (ESMO) 2014 Congress, held September 26–30 in Madrid, Spain.
The first test that can detect the presence of the dengue virus itself rather than antibodies to the virus has been approved for use by the US Food and Drug Administration.
End-stage renal disease (ERSD) is the last stage of chronic kidney disease where the kidneys function at under 10 to 15 percent of their normal capacity. At this stage, kidneys cannot effectively remove waste or excess fluid from the blood system, and dialysis or a kidney transplant is necessary to live.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary Joel Sturm, OD 224 S Gateway Pl Jenks Ok, Suite 101, Jenks, OK 74037-3453 Ph: (918) 747-2020 | Dr Mary Joel Sturm, OD 224 S Gateway Pl, Suite 101, Jenks, OK 74037-3460 Ph: (918) 747-2020 |
News Archive
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
UBM Medica US announces that Cancer Network, a leading online community for oncologists and others who treat cancer and the online home of the journal ONCOLOGY, presents exclusive coverage of the European Society for Medical Oncology (ESMO) 2014 Congress, held September 26–30 in Madrid, Spain.
The first test that can detect the presence of the dengue virus itself rather than antibodies to the virus has been approved for use by the US Food and Drug Administration.
End-stage renal disease (ERSD) is the last stage of chronic kidney disease where the kidneys function at under 10 to 15 percent of their normal capacity. At this stage, kidneys cannot effectively remove waste or excess fluid from the blood system, and dialysis or a kidney transplant is necessary to live.
› Verified 7 days ago
Riverside Eye Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 524 E Main St, Jenks, OK 74037 Phone: 918-296-4733 Fax: 918-296-4734 | |
Insight Eyecare Jenks Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 301 W Main St, Jenks, OK 74037 Phone: 918-296-3937 | |
Riverside Eye Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 524 E Main St, Jenks, OK 74037 Phone: 918-296-4733 | |
Dr. Hannah Sanders, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 224 S Gateway Place, Jenks, OK 74037 Phone: 918-747-2020 | |
Jenks Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 301 W Main St, Jenks, OK 74037 Phone: 918-299-2020 Fax: 918-298-0198 | |
Mr. Brandon Hadel, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 244 S Gateway Place, Suite 401, Jenks, OK 74037 Phone: 918-747-2020 Fax: 918-747-2056 |